135 related articles for article (PubMed ID: 32095082)
1. Effect of RSK4 on Biological Characteristics of Gastric Cancer.
Hu C; Dai J; Lin X; Meng Y; Liang H
Cancer Manag Res; 2020; 12():611-619. PubMed ID: 32095082
[TBL] [Abstract][Full Text] [Related]
2. RSK4 knockdown promotes proliferation, migration and metastasis of human breast adenocarcinoma cells.
Zhu J; Li QY; Liu JL; Wei W; Yang HW; Tang W
Oncol Rep; 2015 Dec; 34(6):3156-62. PubMed ID: 26397146
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
Zhu L; Zhang S; Huan X; Mei Y; Yang H
Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
[TBL] [Abstract][Full Text] [Related]
4. Raltitrexed regulates proliferation and apoptosis of HGC-27 cells by upregulating RSK4.
Hu C; Chen X; Lin X; Dai J; Yu J
BMC Pharmacol Toxicol; 2022 Aug; 23(1):65. PubMed ID: 36031631
[TBL] [Abstract][Full Text] [Related]
5. Effect of RSK4 on biological characteristics of colorectal cancer.
Ye Q; Wang X; Jin M; Wang M; Hu Y; Yu S; Yang Y; Yang J; Cai J
World J Surg Oncol; 2018 Dec; 16(1):240. PubMed ID: 30579335
[TBL] [Abstract][Full Text] [Related]
6. MiR-548d-3p Promotes Gastric Cancer by Targeting RSK4.
Liang H; Hu C; Lin X; He Z; Lin Z; Dai J
Cancer Manag Res; 2020; 12():13325-13337. PubMed ID: 33380838
[TBL] [Abstract][Full Text] [Related]
7. Estradiol promotes the progression of ER+ breast cancer through methylation-mediated RSK4 inactivation.
Li Q; Gao H; Yang H; Wei W; Jiang Y
Onco Targets Ther; 2019; 12():5907-5916. PubMed ID: 31413588
[No Abstract] [Full Text] [Related]
8. Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells.
Thakur A; Sun Y; Bollig A; Wu J; Biliran H; Banerjee S; Sarkar FH; Liao DJ
Clin Cancer Res; 2008 Jul; 14(14):4427-36. PubMed ID: 18628456
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K/AKT signalling pathway.
Mei Y; Liao X; Zhu L; Yang H
J Biochem; 2020 Jun; 167(6):603-611. PubMed ID: 31960922
[TBL] [Abstract][Full Text] [Related]
10. Basic anatomy and tumor biology of the RPS6KA6 gene that encodes the p90 ribosomal S6 kinase-4.
Sun Y; Cao S; Yang M; Wu S; Wang Z; Lin X; Song X; Liao DJ
Oncogene; 2013 Apr; 32(14):1794-810. PubMed ID: 22614021
[TBL] [Abstract][Full Text] [Related]
11. RSK4 inhibits breast cancer cell proliferation and invasion in vitro, and is correlated with estrogen receptor upregulation in breast cancer.
Huo H; Ye X; Yang H; Li Q; Jiang Y
Oncol Rep; 2019 Dec; 42(6):2777-2787. PubMed ID: 31545499
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of the RSK4 promoter associated with BRAF V600E promotes papillary thyroid carcinoma.
Yin Y; Che K; Hu J; Hua H; Dong A; Wang J; Yu J; Zhang Q; Zhao S; Zhao Y; Wang P; Wang F; Wang Y; Chi J; Sun W
Int J Oncol; 2020 May; 56(5):1284-1293. PubMed ID: 32319586
[TBL] [Abstract][Full Text] [Related]
13. [Effects of breast cancer cells stably overexpressing RSK4 on growth of transplanted human breast cancer in severe combined immunodeficiency mice].
Yang HW; Liu JL; Liao DZ; Sun Y; Chen ZS; Zhang XL
Zhonghua Yi Xue Za Zhi; 2012 Jul; 92(26):1845-8. PubMed ID: 22944237
[TBL] [Abstract][Full Text] [Related]
14. Ribosomal S6 kinase 4 (RSK4) expression in ovarian tumors and its regulation by antineoplastic drugs in ovarian cancer cell lines.
Arechavaleta-Velasco F; Zeferino-Toquero M; Estrada-Moscoso I; Imani-Razavi FS; Olivares A; Perez-Juarez CE; Diaz-Cueto L
Med Oncol; 2016 Feb; 33(2):11. PubMed ID: 26732474
[TBL] [Abstract][Full Text] [Related]
15. RKIP suppresses gastric cancer cell proliferation and invasion and enhances apoptosis regulated by microRNA-224.
Liu H; Li P; Li B; Sun P; Zhang J; Wang B; Jia B
Tumour Biol; 2014 Oct; 35(10):10095-103. PubMed ID: 25017365
[TBL] [Abstract][Full Text] [Related]
16. Frequent epigenetic inactivation of RSK4 by promoter methylation in cancerous and non-cancerous tissues of breast cancer.
Li Q; Jiang Y; Wei W; Ji Y; Gao H; Liu J
Med Oncol; 2014 Jan; 31(1):793. PubMed ID: 24338215
[TBL] [Abstract][Full Text] [Related]
17. Low expression of RSK4 predicts poor prognosis in patients with colorectal cancer.
Cai J; Ma H; Huang F; Zhu D; Zhao L; Yang Y; Bi J; Zhang T
Int J Clin Exp Pathol; 2014; 7(8):4959-70. PubMed ID: 25197367
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of the long non-coding RNA SNHG16 contributes to gastric cancer progression and metastasis.
Lian D; Amin B; Du D; Yan W
Cancer Biomark; 2017 Dec; 21(1):151-160. PubMed ID: 29081409
[TBL] [Abstract][Full Text] [Related]
19. Effects of Combination of Anti-CTLA-4 and Anti-PD-1 on Gastric Cancer Cells Proliferation, Apoptosis and Metastasis.
Wang B; Qin L; Ren M; Sun H
Cell Physiol Biochem; 2018; 49(1):260-270. PubMed ID: 30138920
[TBL] [Abstract][Full Text] [Related]
20. Upregulated hsa_circRNA_100269 inhibits the growth and metastasis of gastric cancer through inactivating PI3K/Akt axis.
Wang Z; Liu C
PLoS One; 2021; 16(4):e0250603. PubMed ID: 33901239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
